tiprankstipranks
Algorae Pharmaceuticals Sees Revenue Spike but Net Loss
Company Announcements

Algorae Pharmaceuticals Sees Revenue Spike but Net Loss

Living Cell Technologies Ltd. (AU:1AI) has released an update.

Don't Miss our Black Friday Offers:

Algorae Pharmaceuticals Limited reported a 198% increase in total revenue and other income, rising to $125,200 for the full year ended June 30, 2024, though the company’s net loss marginally improved by 1% to $(2,095,562). The company has not declared any dividends, maintaining a consistent policy from the previous year, and attributes the detailed explanations of the results to the ASX release.

For further insights into AU:1AI stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskAlgorae Pharmaceuticals Expands Pipeline with AI-Driven Targets
TipRanks Australian Auto-Generated NewsdeskAlgorae Pharmaceuticals Plans Major Securities Issuance
TipRanks Australian Auto-Generated NewsdeskAlgorae Pharmaceuticals Streamlines Operations with OTCQB Exit
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App